Intellicule has received a $217,941 NIH SBIR Phase I grant to develop advanced deep-learning software for biomolecular modelling. This technology aims to accelerate novel drug discovery and advance precision medicine by improving cryo-EM analysis.
Professor Heather Sheardown, leader of Innovation Hub C20/20, discusses their research, innovation, and development of new biomaterials-based technologies to treat a variety of disorders in the eye.
János G. Filep, MD from the University of Montreal and Maisonneuve-Rosemont Hospital in Canada, discusses targeting immune mechanisms underlying cardiovascular diseases.
Dr. Josef Penninger led an international team from the University of British Columbia to pioneer a trial drug that could stop infection in the early stages of COVID-19.
David Goff, MD, PhD, Director, Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute at the National Institutes of Health in the U.S., introduces the work of the organisation and his thoughts on supporting heart and vascular health research.
Dr Shiksha Gallow, Medical Director of Biodata and Head Researcher at Cannabis Oil Research, provides evidence-based research on cannabinoids for treating MS and Prostate Cancer.
Emily Y. Chew, M.D., Director of the Division of Epidemiology and Clinical Applications and the Deputy Clinical Director at the National Eye Institute, part of the National Institutes of Health, examines why early detection is crucial to prevent blindness from diabetic retinopathy.
Jane Kinghorn, Director at UCL Translational Research Office and Anne Lane, CEO at UCL Business Ltd describe the contributing factors to the success of accelerating biomedical therapeutic translation at UCL and their partner hospitals.
